Literature DB >> 16014443

Late-onset dementia: structural brain damage and total cerebral blood flow.

Aart Spilt1, Annelies W E Weverling-Rijnsburger, Huub A M Middelkoop, Wiesje M van Der Flier, Jacobijn Gussekloo, Anton J M de Craen, Eduard L E M Bollen, Gerard J Blauw, Mark A van Buchem, Rudi G J Westendorp.   

Abstract

PURPOSE: To prospectively compare indicators of structural brain damage and total cerebral blood flow in patients with late-onset dementia, subjects of the same age with optimal cognitive function, and young subjects.
MATERIALS AND METHODS: The institutional ethics committee approved the studies, and all participants (or their guardians) gave informed consent. The test group included 17 patients older than 75 years (four men, 13 women; median age, 83 years) and with a diagnosis of dementia according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. The control group included 16 subjects (four men, 12 women; median age, 87 years) with optimal cognitive function, who were selected from among 599 elderly subjects enrolled in a population-based follow-up study, and 15 young healthy subjects (seven men, eight women; median age, 29 years). Measurements of intracranial and total brain volumes, structural brain damage, and cerebral blood flow were obtained with magnetic resonance imaging. Mean values were compared with the t test; medians, with the Mann-Whitney U test.
RESULTS: Values for total brain volume were significantly smaller in elderly subjects (P < .001) but did not differ significantly between patients with dementia and subjects of the same age with optimal cognitive function (P = .69). Among the elderly, significantly higher scores for number and extent of white matter areas of signal hyperintensity (P = .028) and lower magnetization transfer ratios (P = .016) indicated greater structural brain damage in those with dementia. Cerebral blood flow was 246 mL/min lower (P < .001) in elderly subjects than in young subjects. In patients with dementia, cerebral blood flow was 108 mL/min lower than that in subjects of the same age with optimal cognitive function (551 vs 443 mL/min, P < .001).
CONCLUSION: The combined observations of more structural brain damage and lower cerebral blood flow in demented elderly individuals than in subjects of the same age with optimal cognitive function support the hypothesis that vascular factors contribute to dementia in old age.

Entities:  

Mesh:

Year:  2005        PMID: 16014443     DOI: 10.1148/radiol.2363041454

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

1.  Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project.

Authors:  Yuriko Katsumata; Hidemi Todoriki; Yasushi Higashiuesato; Shotoku Yasura; D Craig Willcox; Yusuke Ohya; Bradley J Willcox; Hiroko H Dodge
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-20       Impact factor: 6.053

2.  Effect of age and vascular anatomy on blood flow in major cerebral vessels.

Authors:  Sepideh Amin-Hanjani; Xinjian Du; Dilip K Pandey; Keith R Thulborn; Fady T Charbel
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-12       Impact factor: 6.200

3.  Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease.

Authors:  Rodney T Perry; Debra A Gearhart; Howard W Wiener; Lindy E Harrell; James C Barton; Abdullah Kutlar; Ferdane Kutlar; Ozan Ozcan; Rodney C P Go; William D Hill
Journal:  Neurobiol Aging       Date:  2006-12-08       Impact factor: 4.673

4.  Acute effect of a high nitrate diet on brain perfusion in older adults.

Authors:  Tennille D Presley; Ashley R Morgan; Erika Bechtold; William Clodfelter; Robin W Dove; Janine M Jennings; Robert A Kraft; S Bruce King; Paul J Laurienti; W Jack Rejeski; Jonathan H Burdette; Daniel B Kim-Shapiro; Gary D Miller
Journal:  Nitric Oxide       Date:  2010-10-15       Impact factor: 4.427

5.  Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL.

Authors:  Yumi Yamamoto; Masafumi Ihara; Carina Tham; Roger W C Low; Janet Y Slade; Tim Moss; Arthur E Oakley; Tuomo Polvikoski; Raj N Kalaria
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

6.  Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler.

Authors:  Jurgen A H R Claassen; Ramon Diaz-Arrastia; Kristin Martin-Cook; Benjamin D Levine; Rong Zhang
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Serum lipids are related to Alzheimer's pathology in nursing home residents.

Authors:  Gerson T Lesser; Vahram Haroutunian; Dushyant P Purohit; Michal Schnaider Beeri; James Schmeidler; Linda Honkanen; Richard Neufeld; Leslie S Libow
Journal:  Dement Geriatr Cogn Disord       Date:  2009-01-08       Impact factor: 2.959

8.  Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging.

Authors:  Chera L Maarouf; Ian D Daugs; Tyler A Kokjohn; Douglas G Walker; Jesse M Hunter; Jane C Kruchowsky; Randy Woltjer; Jeffrey Kaye; Eduardo M Castaño; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

9.  Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease.

Authors:  Jesse M Hunter; Jason Kwan; Michael Malek-Ahmadi; Chera L Maarouf; Tyler A Kokjohn; Christine Belden; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

10.  Relationship Between Cerebrovascular Reactivity and Cognition Among People With Risk of Cognitive Decline.

Authors:  Donghoon Kim; Timothy M Hughes; Megan E Lipford; Suzanne Craft; Laura D Baker; Samuel N Lockhart; Christopher T Whitlow; Stephanie E Okonmah-Obazee; Christina E Hugenschmidt; Matthew Bobinski; Youngkyoo Jung
Journal:  Front Physiol       Date:  2021-05-31       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.